Arrowhead Moving Into Commercial Territory

 
• By David Wild

Christopher Anzalone is spearheading Arrowhead Pharmaceuticals' transformation from a development-focused to a commercial-stage biotech. The CEO touts an “almost plug and play” platform, a derisked development strategy and a busy pipeline with vast potential.

Transform and succeed or Success transformation and improving as a leadership in business through innovation and evolution concept with paper origami
Arrowhead Is Moving Beyond Its Historic Strenghts in Early-Stage Pipeline Development • Source: Shutterstock

More from Leadership

More from In Vivo